Australian Postnatal Care Guidelines
Published by Living Evidence for Australian Pregnancy and Postnatal Care (LEAPP) on Oct 1, 2024
Disclaimer
Sponsors
This guideline is funded by the Australian Government Department of Health and Aged Care.
Australian Living Evidence Collaboration
School of Public Health and Preventive Medicine, Monash University, Level 4, 553 St Kilda Road, Melbourne, VIC 3004, Australia | ☏
made with
MAGIC
PICOS
PICO 10.1
Population
Women who are breastfeedingIntervention
Not consuming alcoholComparator
Consuming alcoholOutcomes
PICO 20.1
Population
Postnatal womenIntervention
Validated depression assessment toolComparator
Any other tool or any scale of a given toolOutcomes
PICO 30.1
Population
Postnatal womenIntervention
Validated anxiety assessment toolComparator
Any other tool or any scale of a given toolOutcomes
PICO 40.1
Population
Postnatal womenIntervention
Validated psychosocial assessment toolComparator
Any other tool or any scale of a given toolOutcomes
PICO 40.1
Population
Women with preeclampsiaIntervention
Non steroidal anti-inflammatory drugsComparator
ParacetamolOutcomes
PICO 40.2
Population
Women with preeclampsiaIntervention
Routine use of loop diuretics in the postpartum periodComparator
PlaceboOutcomes
PICO 40.3
Population
Women with preeclampsiaIntervention
Beta-blockers (Labetalol 200-800mg BD OR 100-1,200mg QID)Comparator
Calcium channel blockers (Controlled release nifedipine 30-90mg daily)Outcomes
PICO 40.4
Population
Women with preeclampsiaIntervention
ACE-1 inhibitor (Enalapril 5mg daily for 1 week, 10mg daily for 2 weeks and 20mg daily maintenance dose)Comparator
PlaceboOutcomes
PICO 40.5
Population
Women with preeclampsiaIntervention
ACE-I (Captopril maximum of 150mg daily)Comparator
Clonidine maximum of 0.6mg dailyOutcomes
View
made with
MAGIC